Structure of MurNAc 6-phosphate hydrolase (MurQ) from Haemophilus influenzae with a bound inhibitor

Timin Hadi1, Saugata Hazra, Martin E Tanner

  • 1Department of Biochemistry, Albert Einstein College of Medicine , 1300 Morris Park Avenue, Bronx, New York 10461, United States.

Biochemistry
|November 21, 2013
PubMed

Insights

MurNAc 6-phosphate hydrolase (MurQ) recycles peptidoglycan components. Structural and biochemical studies reveal a one-base catalytic mechanism involving Glu89 for N-acetylmuramic acid recycling.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Enzymology

Background:

  • Peptidoglycan is a vital bacterial cell wall component.
  • N-acetylmuramic acid (MurNAc) is a key peptidoglycan subunit.
  • MurNAc 6-phosphate hydrolase (MurQ) is crucial for MurNAc recycling.

Purpose of the Study:

  • To elucidate the catalytic mechanism of MurNAc 6-phosphate hydrolase (MurQ).
  • To identify key active site residues involved in MurQ catalysis.
  • To investigate MurQ as a potential target for mechanistic studies.

Main Methods:

  • Synthesis and testing of competitive inhibitors for MurQ.
  • Cocrystallization of MurNAc 6-phosphate hydrolase from Haemophilus influenzae (MurQ-HI) with a substrate analogue.
  • X-ray crystallography to determine the cocrystal structure.
  • Analysis of active site residue interactions.

Main Results:

  • Substrate and product analogues exhibited competitive inhibition of MurQ-EC.
  • Cocrystal structure revealed Glu89 proximity to inhibitor C2 and C3-oxygen.
  • Conserved residues Glu120 and Lys239 are involved in substrate binding and ring opening.
  • Identified Glu89 as a potential catalytic residue.

Conclusions:

  • Proposed a one-base catalytic mechanism for MurQ.
  • Glu89 acts as the catalytic base, facilitating deprotonation and ether cleavage.
  • The mechanism involves Glu89 in both halves of the catalytic cycle, including water activation.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.2K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.5K